Literature DB >> 17828491

Immunity of unloaded dendritic cells in lung melanoma of mice.

Hongju Liu1, Jianbao Xin, Xiaonan Tao, Dan Shang, Qiong Zhou.   

Abstract

In order to investigate the immunity of unloaded dendritic cells (DCs) derived from murine bone marrow to preexisting lung melanoma metastases of mice, MO5 were intravenously injected to induce lung metastases in syngeneic C57BL/6 mice. Unloaded GM-CSF DCs, PBS and DCs+SIINFEKEL were subcutaneously injected into the mice, which were divided as experimental group, negative control group and positive control group respectively. Monoclonal antibody was used to deplete NK or T cells separately. The immunity-inhibitory effects on the lung melanoma were observed and the corresponding effector cells were examined. It was found that in the experimental and positive groups, the regression was induced in metastatic nodules in the lungs of tumor-bearing mice, but abrogated by treatment with anti-asialo-GM1 but not anti-CD8. It was concluded that the unloaded DCs could suppress the lung melanoma metastases to some extent, which was mediated by NK cells, and could be used as a potent therapeutic agents for lung tumor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17828491     DOI: 10.1007/s11596-007-0408-3

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  8 in total

Review 1.  On guard--activating NK cell receptors.

Authors:  L L Lanier
Journal:  Nat Immunol       Date:  2001-01       Impact factor: 25.606

2.  An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.

Authors:  M B Lutz; N Kukutsch; A L Ogilvie; S Rössner; F Koch; N Romani; G Schuler
Journal:  J Immunol Methods       Date:  1999-02-01       Impact factor: 2.303

3.  Generation of in vitro B-CLL specific HLA class I restricted CTL responses using autologous dendritic cells pulsed with necrotic tumor lysate.

Authors:  Kalathil Suresh; Graeme Fraser; Elizabeth Scheid; Brian Leber; Jack Gauldie; Ronan Foley
Journal:  Leuk Lymphoma       Date:  2006-02

Review 4.  The use of dendritic cells in cancer therapy.

Authors:  M Jefford; E Maraskovsky; J Cebon; I D Davis
Journal:  Lancet Oncol       Date:  2001-06       Impact factor: 41.316

5.  DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction.

Authors:  Christian Adam; Susan King; Thomas Allgeier; Heidi Braumüller; Carolin Lüking; Josef Mysliwietz; Anja Kriegeskorte; Dirk H Busch; Martin Röcken; Ralph Mocikat
Journal:  Blood       Date:  2005-03-15       Impact factor: 22.113

6.  In vitro tumor-pulsed or in vivo Flt3 ligand-generated dendritic cells provide protection against acute myelogenous leukemia in nontransplanted or syngeneic bone marrow-transplanted mice.

Authors:  A B Pawlowska; S Hashino; H McKenna; B J Weigel; P A Taylor; B R Blazar
Journal:  Blood       Date:  2001-03-01       Impact factor: 22.113

Review 7.  Cell-based cancer gene therapy: breaking tolerance or inducing autoimmunity?

Authors:  Juan Carlos Rodriguez-Lecompte; Steve Kruth; Steve Gyorffy; Yong-Hong Wan; Jack Gauldie
Journal:  Anim Health Res Rev       Date:  2004-12       Impact factor: 2.615

8.  Dendritic cell-induced activation of adaptive and innate antitumor immunity.

Authors:  Leon T van den Broeke; Emily Daschbach; Elaine K Thomas; Gerda Andringa; Jay A Berzofsky
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.